Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Breast Cancer, Neurotoxicity
Interventions: Ginkgo Biloba, Placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2015
U.S. locations: 175
States / cities: Scottsdale, Arizona • Lompoc, California • Santa Barbara, California + 111 more

Conditions: Diabetes Mellitus, Type 1
Interventions: Standard Carb Diet, Low Carb Diet; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Coronary Atherosclerosis, Endothelial Dysfunction, Coronary Small Vessel Disease
Interventions: LipiScan/LipiScan IVUS; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sickle Cell Disease
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2044
U.S. locations: 6
States / cities: Peoria, Illinois • Baton Rouge, Louisiana • Charlotte, North Carolina + 1 more

Conditions: Cognitive Impairment, Cognitive Decline, Dementia, Mild
Interventions: RACS app; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Austin, Texas • San Antonio, Texas

Conditions: Bipolar Disorder
Interventions: Modafinil, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Platelet Aggregation Defects
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Mineola, New York

Conditions: TBI (Traumatic Brain Injury), Brain Injuries, Stress, Attention Deficit, Executive Dysfunction
Interventions: State regulation skill training, Treatment-as-usual; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Spinal Cord Injury
Interventions: fermented foods, Control diet, Sitz Marker Test; Other · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Low Back Pain
Interventions: Inspiratory muscle training; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Mild Cognitive Impairment
Interventions: Time-restricted eating; Behavioral
Lead sponsor: Julie Pendergast; Other
Eligibility: 45 Years to 95 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Psoriasis, Cardiovascular Disease
Interventions: Tildrakizumab; Drug
Lead sponsor: Marcelo F. Di Carli, MD, FACC; Other
Eligibility: 18 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognitive Deficit in Attention, Executive Dysfunction, Emotional Regulation
Interventions: Maternal Choline Supplementation 930 mg/d, Maternal Choline Supplementation 480 mg/d; Dietary Supplement
Lead sponsor: Cornell University; Other
Eligibility: 13 Years to 13 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Ithaca, New York

Conditions: Mild Cognitive Impairment, MCI
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Myocardial Injury, COVID-19, Vaccine Reaction
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: Multidomain precision medicine intervention; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction
Interventions: DFree Non-Invasive Bladder Ultrasound, Perifit Kegel Exerciser, Exit interview; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stress Induced Cardiomyopathy
Interventions: I-123 radiolabeled metaiodobenzylguanidine cardiac imaging; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Leukemia, Renal Toxicity
Interventions: methotrexate, medical chart review, assessment of therapy complications; Drug · Other · Procedure
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Up to 21 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Parkinson Disease
Interventions: Placebo, Varenicline; Drug
Lead sponsor: Vikas Kotagal; Other
Eligibility: 45 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cognitive Decline, Cognitive Function
Interventions: MindMD Supplement, Placebo; Dietary Supplement · Other
Lead sponsor: Scale Media Inc; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Heart Failure, Left Ventricular Systolic Dysfunction
Interventions: Vericiguat tablet, Vericiguat suspension, Placebo tablet, Placebo suspension; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 29 Days to 17 Years
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 20
States / cities: Los Angeles, California • Palo Alto, California • San Bernardino, California + 17 more

Conditions: Anxiety, Sexual Dysfunction
Interventions: Gaitril; Drug
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Breast Cancer, Gynecologic Cancer, Sexual Dysfunction, Partner Communication
Interventions: Self-Guided PEPP Intervention Workbook, Self-Guided PEPP Education Workbook; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Knoxville, Tennessee

Search by objective public record fields.

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

Assessment of Coronary Plaque Composition

Sickle Cell Clinical Research and Intervention Program

Cognitive Screening Made Easy for PCPs - Administrative Supplement

Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

Study to Assess Platelet Dysfunction With Verify Now Assay

Brain Markers of Improvements in Cognitive Functioning

Fermented Foods and Bowel Health in SCI

Low Back Pain and Breathing Pattern Dysfunction

Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

MIcrovascular dysfuNction In Moderate-severe Psoriasis

Maternal Choline Supplementation and Offspring Cognition in Adolescence

Neuromodulation of Memory in Aging

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

The Comparative Effectiveness Dementia & Alzheimer's Registry

Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics

Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG

Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia

Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease

A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction

Psychosexual Educational Partners Program (PEPP)